American Shared Hospital Services  

(Public, NYSEMKT:AMS)   Watch this stock  
Find more results for NYSEAMEX:AMS
2.01
0.00 (0.00%)
Jul 21 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.50 - 2.86
Open     -
Vol / Avg. 12.00/5,862.00
Mkt cap 11.31M
P/E     -
Div/yield     -
EPS -0.29
Shares 5.36M
Beta 0.62
Inst. own 8%
Aug 17, 2016
Q2 2016 American Shared Hospital Services Earnings Release (Estimated) Add to calendar
May 10, 2016
Q1 2016 American Shared Hospital Services Earnings Call
May 10, 2016
Q1 2016 American Shared Hospital Services Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 7.83% -3.48%
Operating margin 9.23% -0.97%
EBITD margin - 56.86%
Return on average assets 2.33% -0.95%
Return on average equity 1.01% -7.33%
Employees 9 -
CDP Score - -

Address

4 Embarcadero Ctr Ste 3700
SAN FRANCISCO, CA 94111-4107
United States - Map
+1-415-7885300 (Phone)
+1-415-7885660 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

American Shared Hospital Services provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to approximately 20 medical centers in approximately 20 states in the United States. The Company provides Gamma Knife services through its over 81% indirect interest in GK Financing, LLC (GKF). The Company's business is the outsourcing of stereotactic radiosurgery services and radiation therapy services. The Company provides the equipment, as well as planning, installation, reimbursement and marketing support services. The Company's radiation therapy business consists of one Image Guided Radiation Therapy Operations (IGRT) system. IGRT technology integrates imaging and detection components into a linear accelerator, allowing clinicians to plan treatment, verify positioning and deliver treatment with a single device, providing radiation therapy with less damage to healthy tissue. It is also engaged in proton beam radiation therapy business (PBRT).

Officers and directors

Ernest A. Bates M.D. Chairman of the Board, Chief Executive Officer
Age: 78
Bio & Compensation  - Reuters
Craig Kenji Tagawa Senior Vice President, Chief Operating Officer, Chief Financial Officer
Age: 61
Bio & Compensation  - Reuters
Ernest R. Bates Vice President - Sales and Business Development
Age: 48
Bio & Compensation  - Reuters
John F. Ruffle Lead Independent Director
Age: 78
Bio & Compensation  - Reuters
S. Mert Ozyurek Director
Age: 40
Bio & Compensation  - Reuters
David A. Larson M.D., Ph.D. Independent Director
Age: 74
Bio & Compensation  - Reuters
Raymond C. Stachowiak Independent Director
Age: 57
Bio & Compensation  - Reuters
Stanley S. Trotman Jr. Independent Director
Age: 71
Bio & Compensation  - Reuters